Shivom launch type II Diabetes study in India

KEY TAKEAWAYS:

• Shivom launched their Type II Diabetes project in Andra pradesh, India.
• Shivom will use their Omix Platform to manage genomic data securely across the project.
• The company which combines blockchain, A.I., DNA sequencing & cryptography and is excited to announce it has opened offices in London.

Shivom have launched their Type II Diabetes project in Andra, Pradesh, India. This project will secure patients DNA data on to the OMIX platform and results will be released in 2019.

Patients for the study are being on boarded at SS Diagnostic Clinic and more will be selected in the next 6 months.

Shivom are excited to announce the development of the new Omix Platform, Alpha Release version.

The Alpha version is set to be launched in November this year.

The company, which is a Leading platform working on collaboration & integrity, allowing people to own, manage and monetize their data has expanded it’s global footprint and opened an office in London.

The London team will be led by Dr Natalie Pankova.

Upcoming Events for Shivom

• G4AGH: October 3rd – 5th 2018, Basel
• Malta Blockchain Summit: November 1st – 2nd 2018
• WebSummit: November 5th-8th 2018, Lisbon
• Healthcare Unblocked: November 9th 2018, London

About Shivom

Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.

Register Interest